{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:52:43Z","timestamp":1761864763648,"version":"3.43.0"},"reference-count":10,"publisher":"Scientific Scholar","content-domain":{"domain":["jpalliativecare.com"],"crossmark-restriction":true},"short-container-title":["IJPC"],"abstract":"<jats:p>The management of altered mental status in patients with metastatic cancer is a complex task because of various potential causes such as electrolyte imbalances, brain metastasis, cancer treatments and delirium. Anti-cancer drugs such as methotrexate and cisplatin can cause delirium, and it is crucial to recognise and manage these cases early because of the associated increased morbidity and mortality. This case report presents a rare hyperammonaemic encephalopathy induced by 5-fluorouracil (5FU), a pyrimidine uracil analogue used in gastrointestinal cancers. A 60-year-old woman with metastatic pancreatic adenocarcinoma experienced altered sensorium, incoherent speech and ataxia after chemotherapy, including high-dose 5FU infusion. Her symptoms, along with the exclusion of other common causes, led to a diagnosis of 5FU-induced encephalopathy. Palliative care, supportive care and specific treatments resulted in symptom reversal and discharge with improved functional status. This report emphasises the importance of recognising 5FU-induced encephalopathy for its timely and effective management in clinical practice.<\/jats:p>","DOI":"10.25259\/ijpc_12_2025","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:00:53Z","timestamp":1747994453000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["5-Fluorouracil-induced Reversible Encephalopathy"],"prefix":"10.25259","volume":"0","author":[{"given":"T. M.","family":"Varun","sequence":"first","affiliation":[{"name":"Department of Palliative Medicine, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Prasun","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Advanced Centre for Treatment Research and Education in Cancer - Tata Memorial Centre, Mumbai, Maharashtra, India,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipa","family":"Amte","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"10.25259\/IJPC_12_2025\/ref-1","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2165\/00003495-200363150-00003","article-title":"Neurotoxic Complications of Chemotherapy in Patients with Cancer: Clinical Signs and Optimal Management","volume":"63","author":"Verstappen","year":"2003","journal-title":"Drugs"},{"key":"10.25259\/IJPC_12_2025\/ref-2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated Pyrimidines, a New Class of Tumour-Inhibitory Compounds","volume":"179","author":"Heidelberger","year":"1957","journal-title":"Nature"},{"key":"10.25259\/IJPC_12_2025\/ref-3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4143\/crt.2010.42.2.118","article-title":"A Case of 5-Fluorouracil Induced Encephalopathy","volume":"42","author":"Kwon","year":"2010","journal-title":"Cancer Res Treat"},{"key":"10.25259\/IJPC_12_2025\/ref-4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1345\/aph.18425","article-title":"Fluorouracil-Induced Neurotoxicity","volume":"34","author":"Pirzada","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.25259\/IJPC_12_2025\/ref-5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/bjc.1997.79","article-title":"High-Dose 5-Fluorouracil Infusional Therapy is Associated with Hyperammonaemia, Lactic Acidosis and Encephalopathy","volume":"75","author":"Yeh","year":"1997","journal-title":"Br J Cancer"},{"key":"10.25259\/IJPC_12_2025\/ref-6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/archneur.1970.00480260061008","article-title":"Biochemical Basis for Fluorouracil Neurotoxicity. The Role of Krebs Cycle Inhibition by fluoroaCetate","volume":"23","author":"Koenig","year":"1970","journal-title":"Arch Neurol"},{"key":"10.25259\/IJPC_12_2025\/ref-7","first-page":"1073","article-title":"Effect of the Fluoropyrimidines 5-Fluorouracil and Doxifluridine on Cellular Uptake of Thiamin","volume":"9","author":"Heier","year":"1989","journal-title":"Anticancer Res"},{"key":"10.25259\/IJPC_12_2025\/ref-8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4174\/astr.2016.90.3.179","article-title":"Acute Hyperammonemic Encephalopathy After 5-Fluorouracil Based Chemotherapy","volume":"90","author":"Yi","year":"2016","journal-title":"Ann Surg Treat Res"},{"key":"10.25259\/IJPC_12_2025\/ref-9","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1212\/WNL.0b013e3182904d03","article-title":"Teaching Neuroimages: 5-FU-Induced acute Leukoencephalopathy","volume":"80","author":"Mehta","year":"2013","journal-title":"Neurology"},{"key":"10.25259\/IJPC_12_2025\/ref-10","first-page":"867","article-title":"A case of Hyperammonemic Encephalopathy in a Patient with Recurrent Colon Cancer Treated with Modified FOLFOX6","volume":"36","author":"Teraishi","year":"2009","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Indian Journal of Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jpalliativecare.com\/5-fluorouracil-induced-reversible-encephalopathy\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jpalliativecare.com\/5-fluorouracil-induced-reversible-encephalopathy\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:00:54Z","timestamp":1747994454000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpalliativecare.com\/5-fluorouracil-induced-reversible-encephalopathy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":10,"alternative-id":["10.25259\/IJPC_12_2025"],"URL":"https:\/\/doi.org\/10.25259\/ijpc_12_2025","relation":{},"ISSN":["1998-3735","0973-1075"],"issn-type":[{"type":"electronic","value":"1998-3735"},{"type":"print","value":"0973-1075"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"article-number":"1"}}